tiprankstipranks
Advertisement
Advertisement
Crescent Biopharma 8.095M share Spot Secondary priced at $14.50
PremiumThe FlyCrescent Biopharma 8.095M share Spot Secondary priced at $14.50
22d ago
Crescent Biopharma files ordinary shares offering, no amount given
Premium
The Fly
Crescent Biopharma files ordinary shares offering, no amount given
22d ago
BTIG says others may be interested in Apogee Therapeutics
Premium
The Fly
BTIG says others may be interested in Apogee Therapeutics
1M ago
Crescent Biopharma management to meet with Cantor Fitzgerald
PremiumThe FlyCrescent Biopharma management to meet with Cantor Fitzgerald
4M ago
Crescent Biopharma price target lowered to $22 from $25 at H.C. Wainwright
Premium
The Fly
Crescent Biopharma price target lowered to $22 from $25 at H.C. Wainwright
5M ago
Crescent Biopharma reports Q4 EPS ($4.01) vs. ($19.74) last year
Premium
The Fly
Crescent Biopharma reports Q4 EPS ($4.01) vs. ($19.74) last year
5M ago
Crescent Biopharma announces first patient dosed in ASCENT Phase 1/2 trial
PremiumThe FlyCrescent Biopharma announces first patient dosed in ASCENT Phase 1/2 trial
6M ago
Crescent Biopharma initiated with an Overweight at Piper Sandler
Premium
The Fly
Crescent Biopharma initiated with an Overweight at Piper Sandler
6M ago
Crescent Biopharma initiated with a Buy at Guggenheim
Premium
The Fly
Crescent Biopharma initiated with a Buy at Guggenheim
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100